Taking a Closer Look At Apogee Therapeutics Inc. (APGE) Following Its Recent Trade
Apogee Therapeutics Inc.’s recently made public that its Chief Medical Officer Dambkowski Carl unloaded Company’s shares for reported $0.32 million
Apogee Therapeutics Inc.’s recently made public that its Chief Medical Officer Dambkowski Carl unloaded Company’s shares for reported $0.32 million
Apogee Therapeutics Inc.’s recently made public that its Chief Medical Officer Dambkowski Carl unloaded Company’s shares for reported $0.32 million
Apogee Therapeutics Inc.’s recently made public that its Chief Financial Officer Henderson Jane unloaded Company’s shares for reported $0.29 million
In a filing, Apogee Therapeutics Inc. revealed its Officer HENDERSON MICHAEL THOMAS acquired Company’s shares for reported $1.62 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Apogee Therapeutics Inc. revealed its Chief Executive Officer HENDERSON MICHAEL THOMAS unloaded Company’s shares for reported $0.56
Apogee Therapeutics Inc.’s filing revealed that its Chief Executive Officer HENDERSON MICHAEL THOMAS unloaded Company’s shares for reported $0.56 million
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.